NEW YORK (GenomeWeb News) – While GenMark Diagnostics continues to seek clarification around the consequences of Luminex's collaboration and licensing deal with Natural Molecular Testing, GenMark officials said that it appears that the deal is independent of its own contract with NMT, and NMT is not looking to switch platforms.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.